Comparative study of calcipotriene (MC 903) ointment and fluocinonide ointment in the treatment of psoriasis

Kragballe, 1988, MC903, a non-calciotropic vitamin D3 analogue, stimulates differentiation and inhibits proliferation of cultured human keratinocytes [Abstract], J Invest Dermatol, 91, 383 Binderup, 1988, Effects of a novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo, Biochem Pharmacol, 37, 889, 10.1016/0006-2952(88)90177-3 Kragballe, 1988, Improvement of psoriasis by a vitamin D3 analogue (MC903) in a double-blind study, Br J Dermatol, 119, 223, 10.1111/j.1365-2133.1988.tb03204.x Staberg, 1989, Efficacy of topical treatment in psoriasis with MC903, a new vitamin D analogue, Acta Derm Venereol (Stockh), 69, 147 Kragballe, 1989, Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotriol (MC903), Arch Dermatol, 125, 1647, 10.1001/archderm.1989.01670240047011 Kragballe, 1991, Double-blind right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris, Lancet, 337, 193, 10.1016/0140-6736(91)92157-W Cunliffe, 1992, Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris, J Am Acad Dermatol, 26, 736, 10.1016/0190-9622(92)70103-M Dwyer, 1991, Calcipotriol and hypercalcemia [Letter], Lancet, 338, 764, 10.1016/0140-6736(91)91493-E